Evidence map›Paper›PMID 39886365›Full record

ArticleTechnical innovations & patient support in radiation oncology2025

Integrating knowledge-based planning and noncoplanar oblique VMAT arcs: A study of dose to the heart and immune cells in thoracic radiotherapy.

Brennan Diedrich, Justin Roper, Benjamin Hopkins, Sibo Tian, Shadab Momin, Eduard Schreibmann, Aparna H Kesarwala, Kirk Luca

Abstract read
In one paragraph

Article in Technical innovations & patient support in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Brennan DiedrichDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Justin RoperDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Benjamin HopkinsDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Sibo TianDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Shadab MominDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Eduard SchreibmannDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Aparna H KesarwalaDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Kirk LucaDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.

Funding

Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung CancerR21EB033994 · NIBIB · EMORY UNIVERSITY · PI KESARWALA, APARNA · 2023 to 2025
$822k
NIBIB NIH HHS R21 EB033994
6 · The paper itself

Abstract

Background: Recent patient studies have linked higher immune cell doses with worse quality of life and survival. For thoracic radiotherapy, heart dose is a major contributor to the effective dose to immune cells (EDIC). Purpose: This study investigates heart and immune cell doses for plans optimized using a cardiac-sparing knowledge-based planning (KBP) model and the impact of carefully crafted beam geometry. Methods: Sixteen stage III NSCLC patients previously treated to 60 Gy in 30 fractions using coplanar VMAT arcs were replanned using a cardiac-sparing KBP model with either the clinical field arrangement or noncoplanar oblique arcs that prioritize heart sparing. The cardiac-sparing KBP model consisted of fifteen substructures, all of which were used during optimization. All plans were normalized to 95% PTV coverage at 60 Gy. Statistical significance was assessed for EDIC (Jin Model), along with mean doses to the heart, lungs, body, and both the mean dose and D0.03 cc values for cardiac substructures, using the Wilcoxon signed-rank test. Results: Compared to the clinically treated plans with the same beam geometry, cardiac-sparing KBP reduced mean heart dose from 8.50 Gy to 4.09 Gy and EDIC from 4.27 Gy to 3.81 Gy (p < 0.001). For the novel arcs, the mean heart dose was reduced to 3.70 Gy, significantly lower than KBP with clinical beam geometry (p = 0.001). EDIC, however, was equivalent. No statistically meaningful differences were observed for the remaining organs at risk, and all plans met institutional planning goals. Conclusion: Cardiac-sparing RapidPlan is a valuable tool for reducing heart dose and lowering EDIC in NSCLC patients. Additional heart sparing is possible by strategically crafting noncoplanar oblique beams to minimize heart dose.

Indexed as

Effective Dose to Immune CellsKnowledge-Based PlanningNoncoplanarNon-Small Cell Lung CancerRapidPlan

Identifiers

PMID39886365
PMCPMC11780144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.